1. Home
  2. FPI vs HUMA Comparison

FPI vs HUMA Comparison

Compare FPI & HUMA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Farmland Partners Inc.

FPI

Farmland Partners Inc.

HOLD

Current Price

$9.67

Market Cap

448.2M

Sector

Real Estate

ML Signal

HOLD

Logo Humacyte Inc.

HUMA

Humacyte Inc.

HOLD

Current Price

$0.97

Market Cap

236.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FPI
HUMA
Founded
2013
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Real Estate Investment Trusts
Biotechnology: Pharmaceutical Preparations
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
448.2M
236.0M
IPO Year
2014
N/A

Fundamental Metrics

Financial Performance
Metric
FPI
HUMA
Price
$9.67
$0.97
Analyst Decision
Strong Buy
Analyst Count
0
8
Target Price
N/A
$10.13
AVG Volume (30 Days)
540.3K
4.9M
Earning Date
02-18-2026
11-12-2025
Dividend Yield
2.48%
N/A
EPS Growth
296.76
N/A
EPS
1.27
N/A
Revenue
$52,990,000.00
$1,571,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
$698.97
P/E Ratio
$7.59
N/A
Revenue Growth
N/A
N/A
52 Week Low
$9.37
$0.91
52 Week High
$12.87
$5.48

Technical Indicators

Market Signals
Indicator
FPI
HUMA
Relative Strength Index (RSI) 40.40 32.44
Support Level $9.62 $0.91
Resistance Level $9.73 $1.17
Average True Range (ATR) 0.17 0.08
MACD -0.05 -0.01
Stochastic Oscillator 14.85 15.00

Price Performance

Historical Comparison
FPI
HUMA

About FPI Farmland Partners Inc.

Farmland Partners Inc owns and seeks to acquire high-quality farmland throughout North America. The company is an internally managed real estate company which owns and contracts farmland and storage facilities located across the United States. Majority of the properties in its portfolio are used to grow primary crops, such as corn, soybeans, wheat, rice and cotton, and rest to produce specialty crops, such as almonds, pictachios, citrus, avacados, strawberies, and edible beans. The company generates its revenues through the rent it receives from its tenants.

About HUMA Humacyte Inc.

Humacyte Inc is developing a disruptive biotechnology platform to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine. It develops and manufactures acellular tissues to treat a wide range of diseases, injuries, and chronic conditions. Company's pipeline includes Vascular Trauma, PAD, Dailysis, Acellular Tissue Engineered Vessels, Organ Systems, Advanced Tissue Constructs.

Share on Social Networks: